Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Ambient Audio-Visual Capture for Clinical Documentation and Assessment (BLACKFRAME-AV-)

10 de junio de 2026 actualizado por: BlackFrame.ai

Ambient Audio-Visual Capture for Clinical Documentation, Assessment and Feedback in Medical Education

AI-powered tools that automatically document clinical conversations are being adopted rapidly in outpatient settings but have not been evaluated in hospital wards. Existing tools use audio recording only, which cannot capture physical examination findings, procedural observations, or clinical safety behaviours - elements of a ward round that are visible but not audible.

This study evaluates an ambient audio-visual (AV) capture system - BlackFrame - that uses both microphone and camera to generate accurate clinical documentation and structured educational feedback in a real inpatient surgical ward setting.

Medical students and doctors in training participate in supervised ward round encounters with consenting adult inpatients. The BlackFrame AI platform generates: (a) a structured draft clinical note for the supervising clinician to review and countersign before any use in the patient record; and (b) formative feedback for the trainee, delivered within 30 minutes, covering clinical communication, examination technique, and documentation quality.

The study measures whether AI-generated feedback improves trainee clinical performance over a placement, how much documentation time is saved, and whether the system is acceptable to patients and clinicians. No AI-generated text enters the patient record without explicit clinician review and sign-off. All participation is voluntary.

Descripción general del estudio

Descripción detallada

BACKGROUND

Ambient AI scribes have achieved rapid uptake in outpatient and community settings but all published evaluations use audio-only capture. The inpatient ward round is a multimodal clinical event comprising verbal exchange, physical examination, procedural assessment, and non-verbal observation. Audio-only systems are structurally incapable of capturing observable clinical elements, representing construct under-representation under the Messick validity framework.

No published study has evaluated ambient audio-visual capture in a real inpatient setting, nor measured the educational impact of AI-generated formative feedback on ward rounds.

STUDY DESIGN

Mixed-methods feasibility and educational impact study. Surgical ward round at Yeovil District Hospital as the primary study context. Up to three ambient AV capture devices deployed simultaneously in separate side rooms on each study day. Ward rounds proceed sequentially through each room, allowing up to three consented encounters per study day.

PARTICIPANTS

Trainee participants: medical students (Year 3-5) and doctors in training (FY1 through registrar/ST grade) undertaking supervised clinical activities at the study site.

Patient participants: adult inpatients (age 18 or over) able to provide informed consent, admitted under the surgical team, clinically stable at the time of approach.

TARGET SAMPLE: 60-80 consented encounters across 20-30 trainee participants and up to 80 patient participants.

INTERVENTION

On each study day, eligible patients in up to three side rooms are consented before ward rounds begin. A BlackFrame ambient AV capture device is positioned visibly in each consented patient's room prior to the ward round, with clear patient-facing signage. Devices operate autonomously once positioned and do not require operator presence during the encounter.

The surgical ward round proceeds sequentially through each side room. After each encounter the AI platform produces: (a) a structured draft clinical note for supervising clinician review and countersignature before any use in the patient record; (b) a formative feedback report for the trainee covering clinical communication, examination technique, and documentation quality, delivered within 30 minutes.

OUTCOMES

Primary: (1) Change in trainee assessment scores from baseline to end-of-placement; (2) documentation time saved with versus without AI s

Tipo de estudio

Intervencionista

Inscripción (Estimado)

60

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Niño
  • Adulto
  • Adulto Mayor

Acepta Voluntarios Saludables

Sí

Descripción

Inclusion

Trainee participants:

  • Doctor in training (FY1 through registrar/ST grade) undertaking a supervised clinical activity at a participating NHS study site
  • Able to provide written informed consent in English

Patient participants:

  • Adult inpatient aged 18 years or over
  • Able to provide written informed consent in English
  • Admitted under a surgical team at a participating study site
  • Clinically stable at the time of approach

Exclusion

Trainee participants:

  • Unwilling to be audio-visually recorded
  • Unable to provide written informed consent
  • Any trainee where participation could create a direct conflict with a concurrent formal assessment or appraisal process at that session

Patient participants:

  • Age under 18 years
  • Unable to provide informed consent (including temporary incapacity due to acute illness, sedation, or delirium)
  • Acute clinical deterioration at the time of approach
  • Encounter involves sensitive disclosures in mental health, sexual health, or safeguarding unless a specific sub-protocol with additional consent measures is in place
  • Patient has previously declined participation and does not wish to be re-approached
  • Non-English speaking patients where no appropriate interpreter is available to support the consent process

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Otro
  • Asignación: No aleatorizado
  • Modelo Intervencionista: Asignación de un solo grupo
  • Enmascaramiento: Ninguno (etiqueta abierta)

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Trainee participants
Medical students (Year 3-5) and doctors in training (FY1 through registrar/ST grade) undertaking supervised clinical activities on the surgical ward at the study site. Participants receive AI-generated formative feedback within 30 minutes of each ward round encounter and complete baseline and follow-up clinical assessments.
Fixed camera and microphone array positioned visibly in the patient's room captures the ward round encounter. The AI platform processes the recording to generate: (a) a structured draft clinical note for supervising clinician review and countersignature; (b) a formative feedback report for the trainee covering clinical communication, examination technique, and documentation quality, delivered within 30 minutes of the encounter.
Experimental: Patient participants
Adult inpatients aged 18 or over admitted under the surgical team at the study site, able to provide informed consent and clinically stable at the time of approach. Patients consent to ambient AV recording of their ward round encounter. Their care is unaffected by participation.
Fixed camera and microphone array positioned visibly in the patient's room captures the ward round encounter. The AI platform processes the recording to generate: (a) a structured draft clinical note for supervising clinician review and countersignature; (b) a formative feedback report for the trainee covering clinical communication, examination technique, and documentation quality, delivered within 30 minutes of the encounter.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Mean documentation time per encounter with versus without AI scribe assistance
Periodo de tiempo: Through study completion, approximately 12 weeks
mean difference in time (minutes) to produce a clinical ward round note with versus without AI scribe assistance. Analysed using paired comparison with 95% confidence interval.
Through study completion, approximately 12 weeks

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Cohen's kappa between AI-generated and expert human assessment scores per checklist domain
Periodo de tiempo: Through study completion, approximately 12 weeks
Cohen's kappa coefficient between AI-generated and independent expert human assessment scores, reported per checklist domain
Through study completion, approximately 12 weeks
Trainee-rated feedback quality score on 5-item Likert survey
Periodo de tiempo: After first study encounter, approximately within 1 week of study enrolment
trainee-rated feedback quality, perceived fairness, and utility (5-item Likert survey)
After first study encounter, approximately within 1 week of study enrolment
Blinded expert rating of AI-assisted clinical note completeness and accuracy
Periodo de tiempo: Through study completion, approximately 12 weeks
Structured rating score comparing AI-assisted versus standard ward round note on completeness, accuracy, and clinical safety content, rated by blinded clinical expert assessors
Through study completion, approximately 12 weeks

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Estimado)

1 de septiembre de 2026

Finalización primaria (Estimado)

30 de noviembre de 2026

Finalización del estudio (Estimado)

30 de noviembre de 2026

Fechas de registro del estudio

Enviado por primera vez

1 de junio de 2026

Primero enviado que cumplió con los criterios de control de calidad

10 de junio de 2026

Publicado por primera vez (Actual)

16 de junio de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

16 de junio de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

10 de junio de 2026

Última verificación

1 de junio de 2026

Más información

Términos relacionados con este estudio

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

SÍ

Descripción del plan IPD

As per protocol

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir